Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2016-09-30
2019-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Interviewing to Promote Sustained Breastfeeding
NCT00579605
The Impact of Telelactation Services on Breastfeeding Outcomes
NCT04856163
Mother and Late Preterm Lactation Study
NCT03791749
Stress and Breast Milk Study In the Neonatal Intensive Care Unit
NCT03617549
Text-based Motivational Interviewing Intervention to Promote Exclusive Breastfeeding Rates
NCT06790654
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Prospective participants will contact the investigators via email or by calling the study phone number listed on the advertisements or verbally expressing interest in-person.
3. Once a participant indicates interest by contacting study personnel, a 5-minute screening interview will be conducted with the prospective participant using the screening questionnaire to ensure eligibility criteria are met. For those who do not qualify or agree to participate, the age and reason for non-qualification or declination to participate will be recorded; any other data will be destroyed by shredding or electronic shredding. For those who do qualify, name and contact information will be kept confidential and maintained in a locked room.
4. Participants will be asked to rate on a scale of -10 to +10 about the certainty that the participants will provide exclusive breastmilk to the babies for first six months. Responses from this item will be used as the covariate in the covariate adaptive randomization technique.
5. Eligible subjects will be invited to participate in the study, either in an exam room at West Virginia University's Family Medicine's clinic, participant's home, private room in the Quin Curtis Center for Psychological Services, or in another agreed-upon community location (e.g., church). The location of the study procedures is chosen by the participant.
6. At the start of this session, participants will be given an overview of the study, and the researcher will go over the consent form with the participant.
7. Following consent procedures, video-recording will begin, and all participants will complete the prenatal interview. After this interview, participants will complete five self-report measures, which include the Infant Feeding Knowledge Form, the Iowa Infant Feeding Attitudes Scale, Brief Breastfeeding Attitudes Questions, Perinatal Anxiety Screening Scale, and the Knowledge of Infant Development Inventory.
8. Intervention
1. Participants assigned to the MI condition will receive an approximately 45 minute intervention provided a masters-level supervised psychologist with training in Motivational Interviewing.
2. Participants who have been randomly assigned to participate in the attention-control group session will receive approximately 45 minutes of psychoeducation on typical developmental stages and infant feeding methods.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Motivational Interviewing
Participants assigned to the Motivational Interviewing condition will receive an approximately 45 (± 5) minute intervention provided by a female masters-level supervised psychologist with training in Motivational Interviewing.
Motivational Interviewing
Motivational Interviewing (MI) is a psychosocial intervention designed to help individuals increase readiness for behavior change by increasing intrinsic motivation and resolving ambivalence. MI founders MI conversations help clients change behavior through identifying and resolving discrepancies between goal behaviors and actual behaviors. Behavior change is promoted through the elicitation of "change talk," or client-verbalized arguments for change. In MI, change talk is elicited through two major components: the therapeutic relationship, or the embodiment of the "spirit" of MI, and technical skill.
Psychoeducation Control
Participants who have been randomly assigned to participate in the attention-control group session will receive approximately 45 (± 5) minutes of psychoeducation on typical developmental stages and infant feeding methods. The psychoeducation will be provided by a female masters-level supervised psychologist.
Psychoeducation Control
Psychoeducation on infant development, age 0-15 months, brief education on breastfeeding.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational Interviewing
Motivational Interviewing (MI) is a psychosocial intervention designed to help individuals increase readiness for behavior change by increasing intrinsic motivation and resolving ambivalence. MI founders MI conversations help clients change behavior through identifying and resolving discrepancies between goal behaviors and actual behaviors. Behavior change is promoted through the elicitation of "change talk," or client-verbalized arguments for change. In MI, change talk is elicited through two major components: the therapeutic relationship, or the embodiment of the "spirit" of MI, and technical skill.
Psychoeducation Control
Psychoeducation on infant development, age 0-15 months, brief education on breastfeeding.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Female
3. Pregnant
4. At least 27 weeks pregnant
5. Able to read, write, speak, and understand English
6. Has access to a phone (either mobile or landline)
7. Lives within driving distance of Morgantown, WV, or is willing to travel to a location that is within driving distance to Morgantown, WV
Exclusion Criteria
2. Within one week of due date
3. Has any of the following conditions:
* Developmental or intellectual disability
* Schizophrenia
* Untreated, active tuberculosis
* Human immunodeficiency virus (HIV)/Acquired immunodeficiency syndrome (AIDS)
* Human T-cell lymphotropic virus type I or type II
* History of lumpectomy or radiation to breast
4. Uses or is dependent upon any of the following substances (Moretti, Lee, \& Ito, 2000):
* Heroin
* Cocaine
* Methamphetamines
* Marijuana
* Phencyclidine (PCP)
* Non-prescription opioids (e.g., morphine, oxycodone, hydrocodone)
5. Undergoing any of the following medications/treatments (American Academy of Pediatrics, 2001):
* Antiretrovirals
* Cancer chemotherapy (e.g., antimetabolites)
* Radiation therapy
* Acebutolol
* Atenolol
* Bromocriptine
* Aspirin (salicylates)
* Ergotamine
* Lithium
* Phenobarbital
* Primidone
* Sulfasalazine (salicylazosulfapyridine)
18 Years
99 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West Virginia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel W McNeil, PHD
Role: PRINCIPAL_INVESTIGATOR
West Virginia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Virginia University
Morgantown, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1605123038
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.